Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any non-syndromic X-linked intellectual disability in which the cause of the disease is a mutation in the KIF4A gene.
Features include always present findings: Delayed speech and language development and Intellectual disability; and very common findings: Bilateral tonic-clonic seizure and Generalized non-motor (absence) seizure. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Bilateral tonic-clonic seizure, Delayed speech and language development, Generalized non-motor (absence) seizure |
KIF4A encodes kinesin family member 4A (1,232 aa). Iron-sulfur (Fe-S) cluster binding motor protein that has a role in chromosome segregation during mitosis. Highest expression in Cells EBV-transformed lymphocytes (24.6 TPM) and Cells Cultured fibroblasts (11.5 TPM).
Intellectual disability, X-linked 100 is associated with mutations in the KIF4A gene on chromosome X.
The KIF4A protein participates in Kinesins bind microtubules pathway.
KIF4A is classified as a druggable target with score 0.0.
Genetic testing for KIF4A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, X-linked 100 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 2 very common features.
No clinical trials have been registered for intellectual disability, X-linked 100.
53 publications have been identified in PubMed for intellectual disability, X-linked 100. Research spans Basic Science / Preclinical (23%), Diagnostic / Biomarker (19%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 12 | 23% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:40 AM UTC
Online Mendelian Inheritance in Man
Head and neck | 1 | Abnormal facial shape |
Age of onset: adolescence.
Testing and diagnosis research
10 |
19% |
Research summaries | 9 | 17% |
Patient case studies | 7 | 13% |
Clinical study results | 7 | 13% |
Disease patterns and progression | 7 | 13% |
Other research | 1 | 2% |
Fine AS (2026). [PMID: 41508113](https://pubmed.ncbi.nlm.nih.gov/41508113/). *Orphanet J Rare Dis*. [Other]
Martin KE (2026). [PMID: 41905555](https://pubmed.ncbi.nlm.nih.gov/41905555/). *J Mol Diagn*. [Diagnostic / Biomarker]
Tkemladze T (2026). [PMID: 41044236](https://pubmed.ncbi.nlm.nih.gov/41044236/). *European journal of human genetics : EJHG*. [Diagnostic / Biomarker]
Singin B (2026). [PMID: 40103355](https://pubmed.ncbi.nlm.nih.gov/40103355/). *J Clin Res Pediatr Endocrinol*. [Review / Meta-Analysis]
Pu Q (2026). [PMID: 41888648](https://pubmed.ncbi.nlm.nih.gov/41888648/). *J Neurodev Disord*. [Diagnostic / Biomarker]
Gupta C (2026). [PMID: 41999052](https://pubmed.ncbi.nlm.nih.gov/41999052/). *Ann Neurol*. [Basic Science / Preclinical]
Zhang M (2026). [PMID: 42353815](https://pubmed.ncbi.nlm.nih.gov/42353815/). *Genes (Basel)*. [Basic Science / Preclinical]
Liu N (2026). [PMID: 40884535](https://pubmed.ncbi.nlm.nih.gov/40884535/). *Journal of magnetic resonance imaging : JMRI*. [Diagnostic / Biomarker]
Nunes IS (2026). [PMID: 41087597](https://pubmed.ncbi.nlm.nih.gov/41087597/). *Journal of human genetics*. [Case Report / Case Series]
Burton BK (2026). [PMID: 41547052](https://pubmed.ncbi.nlm.nih.gov/41547052/). *Mol Genet Metab*. [Clinical Trial Publication]